These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1742447)

  • 1. Modelling the influence of risk factors on familial aggregation of disease.
    Aalen OO
    Biometrics; 1991 Sep; 47(3):933-45. PubMed ID: 1742447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial resemblance on the Thurstone Activity Scale, systolic blood pressure, and total cholesterol among first degree relatives of subjects with and without coronary heart disease.
    Carmelli D; Rosenman R
    Genet Epidemiol; 1985; 2(1):55-70. PubMed ID: 4054592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for calculating risk associated with family history of a disease.
    Kerber RA
    Genet Epidemiol; 1995; 12(3):291-301. PubMed ID: 7557350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene by sex interaction in the etiology of coronary heart disease and the preceding metabolic syndrome.
    McCarthy JJ
    Nutr Metab Cardiovasc Dis; 2007 Feb; 17(2):153-61. PubMed ID: 17306735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk estimation for multifactorial diseases. A report of the International Commission on Radiological Protection.
    Ann ICRP; 1999; 29(3-4):1-144. PubMed ID: 11108911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of genetic polymorphisms and conventional risk factors to predict coronary heart disease in patients with familial hypercholesterolemia.
    van der Net JB; Janssens AC; Defesche JC; Kastelein JJ; Sijbrands EJ; Steyerberg EW
    Am J Cardiol; 2009 Feb; 103(3):375-80. PubMed ID: 19166692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors in coronary arteriosclerosis in women].
    Légeret MJ; Darioli R; Grandjean T; Gersbach P; Essinger A; Marazzi A
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1850-3. PubMed ID: 6676937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics: polymorphism and risks.
    Ann Biol Clin (Paris); 1985; 43(4):407-17. PubMed ID: 3867299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating effects of probands' characteristics on familial risk: I. Adjustment for censoring and correlated ages at onset.
    Liang KY
    Genet Epidemiol; 1991; 8(5):329-38. PubMed ID: 1761205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer.
    Baglietto L; Jenkins MA; Severi G; Giles GG; Bishop DT; Boyle P; Hopper JL
    J Clin Epidemiol; 2006 Feb; 59(2):114-24. PubMed ID: 16426946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Score test for familial aggregation in probands studies: application to Alzheimer's disease.
    Commenges D; Jacqmin H; Letenneur L; Van Duijn CM
    Biometrics; 1995 Jun; 51(2):542-51. PubMed ID: 7662843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors.
    Khoury MJ; Beaty TH; Tockman MS; Self SG; Cohen BH
    Genet Epidemiol; 1985; 2(2):155-66. PubMed ID: 3876967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic epidemiology and frequent multifactorial diseases].
    Cambien F
    Rev Epidemiol Sante Publique; 1996 Nov; 44(6):530-9. PubMed ID: 9005488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models.
    Benichou J; Gail MH
    Biometrics; 1990 Dec; 46(4):991-1003. PubMed ID: 2085643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypercholesterolemia in children and young adults: should screening be done?].
    Keller U
    Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart disease.
    Real JT; Ascaso JF; Chaves FJ; Tenés S; Priego MA; Puig O; Armengod ME; Carmena R
    Nutr Metab Cardiovasc Dis; 1999 Feb; 9(1):41-4. PubMed ID: 10726108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
    Neutel JM; Smith DH
    Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple linear model for the effect of changes in metabolic risk factors on coronary heart disease.
    Mogelvang R; Scharling H; Jensen JS
    J Intern Med; 2006 Jun; 259(6):561-8. PubMed ID: 16704556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.